chr3-183825417-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_024871.4(MAP6D1):​c.131G>A​(p.Gly44Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000192 in 1,440,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

MAP6D1
NM_024871.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.825
Variant links:
Genes affected
MAP6D1 (HGNC:25753): (MAP6 domain containing 1) This gene encodes a protein highly similar to the mouse MAP6 domain containing 1 protein, which is related to the STOP proteins. Based on the study of the mouse protein, the encoded protein may function as a calmodulin-regulated neuronal protein that binds and stabilizes microtubules but also associates with the Golgi membranes through N-terminal palmitoylation. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057953447).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP6D1NM_024871.4 linkuse as main transcriptc.131G>A p.Gly44Asp missense_variant 1/3 ENST00000318631.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP6D1ENST00000318631.8 linkuse as main transcriptc.131G>A p.Gly44Asp missense_variant 1/31 NM_024871.4 P1
MAP6D1ENST00000431348.1 linkuse as main transcriptc.131G>A p.Gly44Asp missense_variant 1/32
MAP6D1ENST00000445426.1 linkuse as main transcriptc.107G>A p.Gly36Asp missense_variant, NMD_transcript_variant 1/34

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
151550
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000148
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000109
AC:
6
AN:
55066
Hom.:
0
AF XY:
0.000154
AC XY:
5
AN XY:
32366
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000208
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000197
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000200
AC:
258
AN:
1288514
Hom.:
0
Cov.:
30
AF XY:
0.000191
AC XY:
121
AN XY:
634400
show subpopulations
Gnomad4 AFR exome
AF:
0.0000391
Gnomad4 AMR exome
AF:
0.000147
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000233
Gnomad4 OTH exome
AF:
0.000245
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
151550
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74034
show subpopulations
Gnomad4 AFR
AF:
0.000145
Gnomad4 AMR
AF:
0.000197
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000148
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000356
Hom.:
0
Bravo
AF:
0.000144

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 05, 2023The c.131G>A (p.G44D) alteration is located in exon 1 (coding exon 1) of the MAP6D1 gene. This alteration results from a G to A substitution at nucleotide position 131, causing the glycine (G) at amino acid position 44 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
13
DANN
Benign
0.89
DEOGEN2
Benign
0.0085
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.42
T;T
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.058
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.4
L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
0.69
N;N
REVEL
Benign
0.018
Sift
Benign
0.15
T;T
Sift4G
Benign
0.65
T;T
Polyphen
0.0010
B;.
Vest4
0.068
MutPred
0.16
Loss of catalytic residue at T43 (P = 0.0708);Loss of catalytic residue at T43 (P = 0.0708);
MVP
0.11
MPC
0.0080
ClinPred
0.032
T
GERP RS
-0.66
Varity_R
0.042
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs961100991; hg19: chr3-183543205; API